Physician profile
Mark Benedict Dekutoski
NPI 1386622348
$1,750,550.93
in general payments reported to CMS, 2019-2025
7 companies · $179K in 2025
The $179K reported for 2025 was more than what 95% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184K · 2020: $211K · 2021: $294K · 2022: $305K · 2023: $303K · 2024: $273K · 2025: $179K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $756K · Food and Beverage: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $755,697.00 |
| Food and Beverage | $136.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,354,070.00 | 2021-2025 | Cd Horizon Spinal System |
| Medtronic USA, INC. | $395,172.69 | 2019-2020 | |
| Nuvasive, INC. | $823.83 | 2020-2022 | |
| Nevro Corp. | $167.43 | 2021 | |
| Depuy Synthes Sales INC. | $147.76 | 2021 | |
| Spine Wave, INC. | $136.82 | 2023 | Spinal Implant |
| Zimvie INC. | $32.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Dekutoski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.